Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Viet Nam Pharmaceutical - JSC's quarterly finished goods
increased
from Sep. 2025 (₫1,845,606 Mil) to Dec. 2025 (₫1,988,778 Mil) but then
declined
from Dec. 2025 (₫1,988,778 Mil) to Mar. 2026 (₫1,926,898 Mil).
Viet Nam Pharmaceutical - JSC's annual finished goods
increased
from Dec. 2023 (₫1,378,460 Mil) to Dec. 2024 (₫1,616,540 Mil) and
increased
from Dec. 2024 (₫1,616,540 Mil) to Dec. 2025 (₫1,988,778 Mil).
Viet Nam Pharmaceutical - JSC Inventories, Finished Goods Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Viet Nam Pharmaceutical - JSC Inventories, Finished Goods Chart
What does a Inventories, Finished Goods of ₫1,926,898 Mil mean?
Viet Nam Pharmaceutical - JSC (HSTC:DVN) has a Inventories, Finished Goods of ₫1,926,898 Mil as of Mar. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Viet Nam Pharmaceutical - JSC and its competitors.
Is Viet Nam Pharmaceutical - JSC's Inventories, Finished Goods too high?
Viet Nam Pharmaceutical - JSC's current Inventories, Finished Goods is ₫1,926,898 Mil. Overall, Viet Nam Pharmaceutical - JSC has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Viet Nam Pharmaceutical - JSC's Inventories, Finished Goods compare to ZTS and UTHR?
Viet Nam Pharmaceutical - JSC's Inventories, Finished Goods of ₫1,926,898 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Drug Manufacturers company?
A good Inventories, Finished Goods depends on the Drug Manufacturers industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Viet Nam Pharmaceutical - JSC and its competitors. Viet Nam Pharmaceutical - JSC's current Inventories, Finished Goods is ₫1,926,898 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viet Nam Pharmaceutical - JSC stock overvalued right now?
Based on GuruFocus' analysis, Viet Nam Pharmaceutical - JSC (HSTC:DVN) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫22,079.69, compared to a current price of ₫18,600.00 — trading 15.8% below its estimated fair value. The current Inventories, Finished Goods is ₫1,926,898 Mil. Viet Nam Pharmaceutical - JSC's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Viet Nam Pharmaceutical - JSC (HSTC:DVN), the current Inventories, Finished Goods is ₫1,926,898 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Viet Nam Pharmaceutical - JSC (HSTC:DVN) Overvalued in 2026?
Based on GuruFocus' analysis, Viet Nam Pharmaceutical - JSC stock appears to be undervalued.
The current stock price of ₫18,600.00 is trading 15.8% below its estimated GF Value™ of ₫22,079.69.
GuruFocus considers Viet Nam Pharmaceutical - JSC to be Modestly Undervalued.
Key valuation signals for HSTC:DVN:
Inventories, Finished Goods: ₫1,926,898 Mil
GF Value™: ₫22,079.69 vs. price of ₫18,600.00 (15.8% below fair value)
No single metric tells the full story. See the HSTC:DVN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Viet Nam Pharmaceutical - JSC Business Description
Viet Nam Pharmaceutical Corp - JSC is engaged in the manufacturing of drugs. The company provides testing services for drugs and medicinal ingredients.
80GF Score
Get the complete analysis for HSTC:DVN
Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSTC:DVN has been successfully added to your 
